Introduction
HTPS300 is a high‑throughput proteomic screening platform developed for rapid, automated analysis of protein samples in both research and clinical settings. The system combines advanced liquid chromatography, tandem mass spectrometry, and data‑analysis algorithms to deliver quantitative protein expression profiles with high reproducibility. Since its initial release, HTPS300 has been widely adopted in biomedical research, drug discovery, and diagnostic laboratories around the world.
History and Development
Origins in Proteomics Research
The conceptual foundation of the HTPS300 platform can be traced back to the early 2000s, when proteomics emerged as a critical field for understanding cellular biology. Researchers sought a more efficient way to process large sample sets while maintaining the sensitivity and accuracy required for quantitative analysis. The need for an integrated system that automated sample preparation, chromatographic separation, mass spectrometric detection, and data interpretation drove the design of the HTPS300.
Prototype and Early Testing
In 2006, a multidisciplinary team of engineers, chemists, and software developers at the Institute for Proteomic Technologies constructed a prototype of the HTPS300. Initial testing focused on validating the system’s capability to handle 96‑well plate formats, ensuring that the fluidics could deliver precise aliquots without cross‑contamination. Early results demonstrated a five‑fold increase in throughput compared with conventional manual workflows.
Commercial Launch and Subsequent Iterations
The first commercial version, labeled HTPS300A, was launched in 2009. This model introduced a modular cartridge system that allowed users to swap between different chromatographic columns and mass‑spectrometer configurations. In 2013, the HTPS300B revision incorporated a higher‑resolution quadrupole‑time‑of‑flight mass spectrometer and an updated software suite that enabled label‑free quantitation. Continuous updates through 2024 have kept the platform at the forefront of proteomic technologies.
Technical Specifications
Hardware Components
- Liquid Chromatography Module – Capable of operating at flow rates ranging from 100 µL min‑1 to 1 mL min‑1 with pressure limits up to 10,000 psi.
- Mass Spectrometer – Quadrupole‑time‑of‑flight architecture offering a mass range of 50–2000 m/z and a resolving power of 40,000 at m/z 400.
- Sample Handling Unit – Automated pipetting station that can process 96‑well plates with a precision of ±0.5 µL.
- Data Acquisition Processor – Dedicated embedded system that streams raw data to a connected workstation via Gigabit Ethernet.
Software Architecture
The HTPS300 software suite is organized into three primary modules: Workflow Manager, Spectral Analyzer, and Reporting Engine. The Workflow Manager coordinates sample routing, reagent dispensing, and instrument calibration. The Spectral Analyzer applies peak‑fitting algorithms and performs database searches against the UniProt proteome. The Reporting Engine compiles results into standard formats such as CSV, PDF, and XML, facilitating downstream analysis.
Performance Metrics
Benchmarks indicate that the HTPS300 can process 480 samples per day under standard operating conditions, with a coefficient of variation (CV) for protein quantitation below 7 %. The system achieves a detection limit of 0.1 ng µL‑1 for most target proteins, depending on the chosen chromatography setup.
Key Features and Concepts
Automated Sample Handling
The automated sample handling subsystem integrates robotic arm movement, microfluidic valves, and sensor feedback to ensure accurate transfer of reagents and samples. This automation reduces manual labor and minimizes the risk of human error, leading to more consistent data.
Data Acquisition Workflow
Each sample undergoes a standardized workflow: protein extraction, enzymatic digestion, desalting, and injection into the chromatographic column. Mass spectrometric detection captures MS/MS spectra that are subsequently analyzed to identify and quantify peptides. The entire process is fully automated and monitored in real time.
Data Analysis Algorithms
HTPS300 utilizes a hybrid search strategy combining sequence database matching and de novo sequencing. Quantitative analysis employs intensity‑based label‑free methods, with optional isobaric labeling support for comparative studies. The software also applies statistical filters to control false discovery rates at 1 % at the protein level.
Applications
Biomedical Research
Researchers use the HTPS300 to map proteomic changes in disease models, identify biomarkers, and study protein‑protein interactions. The platform’s high throughput enables large cohort studies, making it suitable for investigations involving thousands of samples.
Drug Discovery
Pharmaceutical companies employ HTPS300 for target validation, mechanistic studies, and screening of therapeutic compounds. The system’s rapid turnaround allows researchers to quickly assess the proteomic impact of candidate drugs.
Clinical Diagnostics
In clinical laboratories, the HTPS300 is used for proteomic profiling of patient samples to diagnose conditions such as cancers, metabolic disorders, and infectious diseases. Its compliance with regulatory standards ensures reliable results for clinical decision‑making.
Agricultural Science
Plant scientists use the platform to analyze protein expression in crops under various environmental conditions. This information assists in breeding programs aimed at improving yield, stress tolerance, and nutritional value.
Compatibility and Standards
Hardware Interfaces
The HTPS300 communicates via USB 3.0, Ethernet, and RS‑232 ports. It supports standard 96‑well plate formats and is compatible with a range of chromatographic columns, including reverse‑phase C18 and mixed‑mode ion‑exchange options.
Data Formats
Output files are available in widely accepted formats such as mzML for raw spectra, pepXML for peptide identifications, and mzQuantML for quantitative data. These formats facilitate integration with other bioinformatics tools.
Regulatory Compliance
Manufacturers provide documentation supporting compliance with ISO 15189 for medical laboratories and ISO 17025 for general analytical laboratories. The software includes audit trails and data integrity features required by regulatory bodies.
Model Variants and Accessories
HTPS300A and HTPS300B
The HTPS300A variant prioritizes modularity, allowing users to customize instrument configurations. The HTPS300B, introduced in 2013, offers enhanced mass spectrometer resolution and expanded software capabilities.
Sample Kit Series
- Proteome Extraction Kit – Contains reagents for rapid cell lysis and protein solubilization.
- Digestion Kit – Supplies trypsin, LysC, and other proteases for efficient protein cleavage.
- Desalting Columns – Pre‑packed cartridges that remove salts and buffer components prior to chromatography.
Software Suite Extensions
Optional modules include a Proteome Explorer for interactive data visualization, a Biomarker Discovery Toolkit for statistical analysis, and a Data Integration Module that links HTPS300 output to laboratory information management systems (LIMS).
Operational Procedure
Setup and Installation
Installation requires a stable power supply, a controlled environment with temperature set to 20 °C ± 2 °C, and a dedicated workbench. The system must be leveled within 0.5 mm to ensure accurate fluidic delivery.
Calibration
Daily calibration involves running a standard peptide mixture to verify mass accuracy and chromatographic performance. The software automatically records calibration metrics and alerts users if deviations exceed predefined thresholds.
Run Protocol
- Load a 96‑well plate with prepared samples into the sample tray.
- Configure the desired workflow through the Workflow Manager.
- Initiate the run; the system will handle reagent addition, sample injection, chromatographic separation, and mass spectrometric detection.
- Upon completion, the Spectral Analyzer processes raw data and the Reporting Engine generates output files.
Maintenance
Routine maintenance includes cleaning of the sample handling unit, replacement of worn seals, and software updates. The system logs maintenance activities to support traceability.
Troubleshooting
Common Issues
- Clogged Pipette Tips – Inspect tips for debris; replace if clogged.
- Mass Spectrometer Drift – Re‑calibrate using the standard peptide mixture.
- Data Loss – Verify that the data acquisition processor is correctly connected to the workstation.
Diagnostics
The built‑in Diagnostics Module can run self‑tests on fluidic lines, sensor functionality, and hardware integrity. Results are displayed in a diagnostic dashboard accessible via the software interface.
Support Resources
Manufacturers provide detailed user manuals, video tutorials, and a knowledge base. Technical support is available by phone and email during business hours, with priority escalation for critical issues.
Impact and Evaluation
Performance Benchmarks
Independent validation studies have shown that HTPS300 achieves a peptide identification rate of 90 % for standard proteomic libraries, with a CV of 5 % for protein quantitation. These figures compare favorably with competitor systems that average 80 % identification rates.
Comparative Studies
In a head‑to‑head comparison with other high‑throughput platforms, HTPS300 demonstrated superior speed in processing 96‑well plates, achieving a 25 % reduction in total run time while maintaining data quality.
Market Reception
Since 2009, over 500 units of HTPS300 have been sold worldwide, with a growing presence in academic, government, and industrial research facilities. User surveys report high satisfaction with automation features and data reliability.
Future Developments
Planned Enhancements
Future releases aim to integrate ion mobility separation for increased resolution and to incorporate machine learning algorithms that predict optimal instrument settings based on sample characteristics.
Research Roadmap
Collaborations with academic institutions are underway to explore the application of HTPS300 data in systems biology and personalized medicine. Funding from national research agencies supports the expansion of the platform’s analytical capabilities.
No comments yet. Be the first to comment!